SCINTIX biology-guided radiotherapy now FDA cleared.
SCINTIX® therapy detects and responds to signals emitted from the cancer itself and, for the first time, uses them to deliver immediate treatment for tumors in the lung or bone that may arise from primary or metastatic disease.
ActivTrak provides the work intelligence organizations need to understand and improve work in the AI era. Our award-winning technology combines privacy-first behavioral data across people, process and technology to provide a continuous view of how work gets done. This helps leaders measure AI impact, optimize productivity and capacity, identify workflow and automation opportunities and improve operational performance.
The platform also powers research through the ActivTrak Productivity Lab. Drawing on one of the world's largest behavioral datasets on work activity, the Lab studies thousands of organizations to reveal how productivity, AI adoption and collaboration change over time.
ActivTrak is trusted by more than 9,500 organizations worldwide and recognized by Deloitte’s Technology Fast 500, Inc. 5000, TrustRadius and G2. The company is backed by Elsewhere Partners, Sapphire Ventures and Francisco Partners.
At Teramind, we're pioneering a predictive, AI-driven approach to safeguarding organizations' people, data, and operations. As a global leader in user behavior analytics, insider risk management, and workforce intelligence, we empower businesses to transform data into a strategic asset- delivering clear visibility, control, and proactive protection across digital environments.